Atlas Trials

Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

Clinical trial NCT06940700 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06940700
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2025-04-01
Primary completion
2025-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.